BBIBP-CorV Vaccine from CNBG China National Biotec Group Company Limited (Sinopharm)

Beijing Institute of Biological Products

Clinical  Stage:phase 3

and Approved by

  • United Arab Emirates
  • China
  • Bahrain

Vaccine platform:Inactivated

Type of candidate vaccine: Inactivated

Number of doses:2

Timing of doses:0,21 days

Route of Administration: IM
Phase 3 report:

Phase 1/2 report: